The 20 Best Idiopathic Pulmonary Fibrosis Doctors Near Me in Ann Arbor, MI

Director of the Michigan Medicine Interstitial Lung Disease program, Vice-Chair of the Medical School Institutional Review Board for Human Subjects Research, Associate Program Director Internal Medicine Residency Program - Research, Co-Director University of Michigan Medical School Scientific Discovery Pathway, Steering committee chair for the pulmonary fibrosis foundations Care Center Network and Patient Registry. Dr. Flaherty is rated as an Elite provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Lung Transplant. Dr. Flaherty is board certified in Pulmonary Disease.

Justin Oldham is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Oldham is rated as an Elite provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, and Lung Transplant.

Dr. O’Dwyer is an Assistant Professor in the Division of Pulmonary and Critcial Care Medicine at the University of Michigan. He graduated from University College Cork Medical School, National University of Ireland in 2004. Dr. O’Dwyer completed his internal medicine residency training through the Royal College of Surgeons of Ireland and was awarded membership of the Royal College of Physicians (RCPI) in 2007. He completed a clinical fellowship in internal medicine and pulmonary medicine at St.Vincents University Hospital and the Royal College of Physicians in 2014. He completed research training in pulmonary medicine graduating with a PhD in pulmonary fibrosis from University College Dublin, National University of Ireland in 2014. He completed clinical fellowship training in pulmonary and critical care medicine at the University of Michigan in 2017. Dr. O'dwyer is rated as an Elite provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, and Pulmonary Fibrosis. Dr. O'dwyer is board certified in Internal Medicine and Pulmonary Disease.

Elizabeth Belloli is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 17 years. Dr. Belloli is rated as an Elite provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Pulmonary Fibrosis, and Lung Transplant.

Eric White is a Pulmonary Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. White is rated as an Elite provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Dr. Hyzy is the Medical Director of the Critical Care Medicine Unit and Co-Chair of the Critical Care Committee at the University of Michigan Hospital. Dr. Hyzy is a graduate of Kenyon College and NYU School of Medicine and trained in Internal Medicine and Pulmonary and Critical Care Medicine at the University of Michigan. Dr. Hyzy’s research interest in thin the intensive care unit including patients with the Acute Respiratory Distress Syndrome, sepsis and respiratory failure. In the Pulmonary Clinic he participated as a Co-Investigator in clinical trials in patients with Idiopathic Pulmonary Fibrosis and COPD. Dr. Hyzy is an active clinician and researcher with multiple publications including serving as editor of a critical care textbook published by Springer and 14 topics to the online medical reference UpToDate. Dr. Hyzy is rated as a Distinguished provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Pneumonia, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis.

Steven Huang, MD is an Associate Professor in the Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine at the University of Michigan. He did his undergraduate studies at Northwestern University in Evanston (1994-1997), and went to Medical School at Northwestern University in Chicago (1997-2001). After completing his internship and residency in Internal Medicine also at Northwestern, he came to the University of Michigan for fellowship in Pulmonary and Critical Care Medicine (2004-2007). He stayed on as faculty, first as a Clinical Lecturer, and then as a tenured-track faculty member.Dr. Huang's research focuses on understanding how epigenetic modifications contribute to the development of chronic lung diseases, especially idiopathic pulmonary fibrosis (IPF). He focuses on studying how fibroblasts contribute to disease pathology and how patients develop variability in disease progression. His work also examines how air pollution contributes to the development of asthma. Dr. Huang is in charge of helping maintain the U of M ILD Lung Biorepository.Dr. Huang is an active member of several pulmonary subspecialty societies, including the American Thoracic Society (ATS), and has received career-development awards from the ATS. His research is funded by the National Institutes of Health. He sees a variety of patients in his general pulmonary medicine clinic, and he is the Medical Director of Michigan Medicine's Pulmonary Rehabilitation Program. Dr. Huang is rated as a Distinguished provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, and Interstitial Lung Disease. Dr. Huang is board certified in Pulmonary Disease and Critical Care Medicine.

Bonnie Wang is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Veno-Occlusive Disease, and Pulmonary Hypertension.

Timothy Blackwell is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Blackwell is rated as an Advanced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Pulmonary Fibrosis, Interstitial Lung Disease, Acute Interstitial Pneumonia, and Pneumonia. Dr. Blackwell is board certified in Pulmonary Disease and Critical Care Medicine.

Dr. Pugashetti is an Assistant Professor at the University of Michigan, in the Division of Pulmonary and Critical Care. After receiving her undergraduate degree from UCLA, she went on to receive her medical degree, Internal Medicine training, and fellowship in Pulmonary and Critical Care at UC Davis. Dr. Pugashetti has also completed a Master’s Degree in Epidemiology. She joined Michigan Medicine in 2022, where she now provides expert care for patients with interstitial lung disease (ILD) at the Taubman Pulmonary Clinic. She also staffs the Connective Tissue Disease-Associated ILD Clinic (CTD-ILD) where she works closely alongside Rheumatology colleagues. She leads the Interstitial Lung Disease program at the Ann Arbor VA. Dr. Pugashetti is rated as an Advanced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Lung Transplant. Dr. Pugashetti is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.

Dr. Dickson's laboratory specializes in integrative translational research, spanning from molecular characterization of respiratory microbiota to animal modeling of acute lung disease to prospective trials of human subjects. His work has been published in Nature Microbiology, The Lancet, the American Journal of Respiratory and Critical Care Medicine and Lancet Respiratory Medicine. He is an Associate Director of the Michigan Center for Integrative Research in Critical Care, a member of the Editorial Board of Lancet Respiratory Medicine, and an Associate Editor of Microbiome. Dr. Dickson is rated as an Advanced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Pneumonia, Acute Respiratory Distress Syndrome (ARDS), Acute Interstitial Pneumonia, Lung Transplant, and Endoscopy. Dr. Dickson is board certified in Pulmonary Disease and Critical Care Medicine.

Dr. Schneider attended medical school at The University of Texas Health Sciences Center, Houston, TX and also obtained his Ph.D. in Biomedical Sciences from the University of Texas. Later, he completed an Internal Medicine residency at the University of Michigan, Ann Arbor, MI. Afterwards, he completed a fellowship in Pulmonary and Critical Care Medicine from the University of Michigan. In 2017, Dr. Schneider joined the University of Michigan Health System as a Clinical Lecturer in Internal Medicine. Dr. Schneider is rated as an Advanced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Systemic Sclerosis (SSc), and Lung Metastases.

Dr. Lyu attended medical school at Vanderbilt University School of Medicine, Nashville, TN and completed an Internal Medicine residency in the Osler Medical Service at Johns Hopkins Hospital, Baltimore, MD. Later, he completed a fellowship in Pulmonary and Critical Care Medicine from the University of Colorado Health Sciences, Aurora, CO. Next, he completed another fellowship in Lung Transplantation also from the University of Colorado Health Sciences. Afterwards he worked as an Instructor of Medicine, Assistant Professor, and most recently Associate Professor in Lung Transplant and Pulmonary/Critical Care Medicine at the University of Colorado Health Sciences. In 2017, Dr. Lyu joined the University of Michigan Health System as a Clinical Associate Professor in the Division of Pulmonary and Critical Care Medicine. Dr. Lyu is rated as an Advanced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Bronchiolitis Obliterans, Acute Interstitial Pneumonia, Hypersensitivity Pneumonitis, Lung Transplant, and Endoscopy. Dr. Lyu is board certified in Pulmonary Disease and Critical Care Medicine.

Philip Choi is an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Choi is rated as an Advanced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Obesity Hypoventilation Syndrome (OHS), Secondary Immunodeficiency (SID), and Lung Metastases.

Dr. Benjamin Singer is an Assistant Professor in Pulmonary and Critical Care Medicine in the Department of Internal Medicine at the University of Michigan. He received his undergraduate degree in mathematics at the University of Michigan in 2002. Dr. Singer completed his medical training and PhD in Neuroscience through the Medical Scientist Training Program, and subsequently completed residency in Internal Medicine and fellowship training in Pulmonary and Critical Care Medicine, all at the University of Michigan.Approximately half of patients who survive an episode of critical illness experience long term brain dysfunction, in the form of anxiety, depression, post traumatic stress, or cognitive impairment. Dr. Singer’s research focuses on basic and translational studies of long-term brain injury after critical illness, with a focus on sepsis. These studies utilize animal models of sepsis and patient autopsy specimens to examine the immune and vascular responses to sepsis in the brain that persist for weeks to months after the outward signs of illness have resolved. In collaboration with Dr. Bob Dickson, he also examines the role of the gut microbiome in initiation of brain injury and multiorgan failure during sepsis. The goal of this work is to identify strategies to minimize and rehabilitate ongoing brain injury in sepsis survivors. Areas of special clinical focus include the care of patients with advance neuromuscular disease requiring chronic assisted ventilation. Dr. Singer is supported by a National Institute of Neurological Disorders and Stroke Career Development Award, MICHR, and University of Michigan Depression Center. Dr. Singer is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Acute Interstitial Pneumonia, Obesity Hypoventilation Syndrome (OHS), and Interstitial Lung Disease. Dr. Singer is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.

Dr. Valley is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine in the Department of Medicine at the University of Michigan. He received his undergraduate degrees in history and chemistry from Emory University, and his medical degree from the University of Miami. He completed his internal medicine residency at the University of Texas-Southwestern/Parkland Memorial Hospital, where he also served as Chief Medical Resident. He completed a fellowship in pulmonary and critical care medicine at the University of Michigan in 2016. During his fellowship, he earned a Masters of Health and Healthcare Research from the University of Michigan.Clinically, Dr. Valley focuses on the care of critically ill patients and their families. He practices in the Critical Care Medicine Unit at the University of Michigan and the Medical Intensive Care Unit at the Ann Arbor VA. He is the Director of the Ann Arbor VA's Post-ICU Survivor Care, Evaluation, and Support (PISCES) Clinic.Dr. Valley's research seeks to improve the delivery of care within ICUs. Currently, he has two broad research focuses: reducing disparities in ICU care among rural and minoritized communities and ensuring that ICU care is centered around patients and families. His work has been supported by the NIH/NHLBI, the Agency for Healthcare Research and Quality, and the VA Health Services Research and Development Service. Dr. Valley is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses COVID-19, Pneumonia, Systemic Sclerosis (SSc), and Cerebral Hypoxia.

Dr. Kim attended medical school at The University of Michigan, Ann Arbor, MI and completed an internal medicine residency from the University of Michigan Health System. Later, he completed a fellowship in Pulmonary and Critical Care Medicine from the University of California, San Francisco, CA. After serving as a faculty member at the University of California, San Francisco from 2005-2010, Dr. Kim joined the University of Michigan as an Assistant Professor in July 2010. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Metastases, Emphysema, and Gastrostomy.

Jennifer Wang is an Internal Medicine specialist and a Pulmonary Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Emphysema, and Pulmonary Fibrosis. Dr. Wang is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.

Sean Fortier is an Internal Medicine specialist and a Pulmonary Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Fortier is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. His clinical expertise encompasses Cystic Fibrosis, Acute Interstitial Pneumonia, Pulmonary Fibrosis, and Lung Metastases. Dr. Fortier is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.

Leadership roles: Adult Co-Director, Cystic Fibrosis Foundation Therapeutics Development Center; Associate Director, University of Michigan Adult Cystic Fibrosis Program; Medical Director, Bronchiectasis and NTM Care Center. Dr. Jia is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Bronchiectasis, and Lung Transplant. Dr. Jia is board certified in Pulmonary Disease and Critical Care Medicine.